This week, the CDC signed off on the FDA’s authorization of the bivalent COVID-19 booster shot for children as young as five years old.
The bivalent vaccine targets the omicron variant, which continues to be the dominant strain across the country
The Pfizer booster can be given at least two months following completion of the primary vaccine series in children five years and older while Moderna’s booster is authorized for children six years and older.
The CDC reports that just over 30 percent of children as young as five have had the primary vaccine.